Updated Guidance on Exception from Informed Consent for IRBs, Clinical Investigators, and Sponsors

May 1, 2013

The Food and Drug Administration and the US Department of Health and Human Services released an updated Guidance for Institutional Review Boards, Clinical Investigators and Sponsors on Exception from Informed Consent Requirements for Emergency Research.  This update clarifies some confusing or inconsitent language in the last update from March 2011.